健康老年人抗生素使用与后续认知下降及痴呆风险
研究基于ASPirin in Reducing Events in the Elderly试验的前瞻性随访与观察性延伸,纳入13,571名社区澳大利亚老年人,中位随访4.7年。调整混杂因素后,任何或重复抗生素使用与痴呆(HR 1.03;95%CI 0.84-1.25)、认知障碍但非痴呆(CIND;HR 1.02;95%CI 0.94-1.11)及认知评分下降均无关联。
要点
- 在初始健康的老年人中,任何或重复抗生素使用与痴呆风险无关联。
- 抗生素使用与CIND风险及认知评分纵向下降均无关联。
- 按累积频率、长期使用或特定抗生素类别分析,亦未发现关联。
核心结论
- 在初始健康的老年人中,任何或重复抗生素使用与痴呆、CIND或加速认知下降无关联。
- 作者认为结果不支持抗生素相关肠道微生物组紊乱与痴呆风险存在关联。
研究设计与样本
- 研究为ASPirin in Reducing Events in the Elderly试验的前瞻性随访与观察性延伸,该试验为已在社区澳大利亚老年人中完成的随机试验。
- 纳入处方记录可获取且随访前2年无痴呆的参与者,共13,571人(平均年龄±SD 75.0±4.1岁,54.3%为女性)。
- 根据解剖治疗化学代码(J01)识别前2年内任何或重复抗生素使用。
- 采用线性混合模型评估抗生素使用与标准化复合及领域特异性认知评分纵向变化的关联。
- 采用Cox比例风险模型评估抗生素使用与临床裁定的痴呆及CIND的关联。
主要发现
- 第二次随访访视后中位4.7年内,13,571名参与者中记录到461例痴呆和2,576例CIND。
- 与未使用相比,抗生素使用与痴呆风险增加无关联(HR 1.03;95%CI 0.84-1.25)。
- 与未使用相比,抗生素使用与CIND风险增加无关联(HR 1.02;95%CI 0.94-1.11)。
- 与未使用相比,抗生素使用与后续认知评分下降无关联。
- 按累积使用频率、长期使用、特定抗生素类别(如β-内酰胺类、四环素类和磺胺类)及风险因素定义的亚组分析,均未发现关联。
临床怎么用
- 原文未据此给出推荐。
局限性
- 处方数据可能不能反映实际使用情况。
- 作者通过检查定义时间段内抗生素使用频率来捕捉暴露程度和持续时间。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Antibiotics rapidly reduce intestinal bacterial diversity, leading to dysbiosis that persists for months to years. Although emerging evidence from retrospective and claims-based studies has linked dysbiosis to cognitive function, prospective data are lacking. We aim to examine the prospective association of antibiotics with cognitive aging among initially healthy older adults. METHODS: We leveraged data from prospective follow-up and observational extension of ASPirin in Reducing Events in the Elderly, a completed randomized trial of community-based Australian older adults. Among participants whose prescription records were available and without dementia during the first 2 years of follow-up, we identified any or repeated antibiotic use based on the Anatomical Therapeutic Chemical code (J01). We assessed the associations of antibiotic use during the first 2 years with longitudinal changes in standardized composite and domain-specific cognitive scores (global cognition, episodic memory, language and executive function, and psychomotor speed) using linear mixed models, and with incident, clinically adjudicated dementia (Diagnostic and Statistical Manual for Mental Disorders, Fourth Edition criteria) and incident cognitive impairment, no dementia (CIND, without a dementia trigger but with significant, nontransient decline), using Cox proportional hazard models. RESULTS: Over a median of 4.7 years after the second follow-up visit, we documented 461 dementia and 2,576 CIND cases among 13,571 participants (mean age ± SD 75.0 ± 4.1 years, 54.3% female). Compared with nonuse, antibiotic use was not associated with increased risks for dementia (hazard ratio [HR] 1.03; 95% CI 0.84-1.25), CIND (HR 1.02; 95% CI 0.94-1.11), or subsequent declines in cognitive scores, after adjusting for sociodemographic, lifestyle factors, family history of dementia, baseline cognitive function, and medications known to affect cognition. There were also no associations according to the cumulative frequency of antibiotic use, long-term use, specific antibiotic classes (e.g., beta-lactams, tetracyclines, and sulfonamides), and subgroups defined by risk factors. DISCUSSION: Among initially healthy older adults, any or repeated antibiotic use was not associated with incident dementia, CIND, or accelerated cognitive decline. Although prescription data may not reflect the actual use, we examined the frequency of antibiotics within a defined period to capture the extent and duration of antibiotic exposure. Our results do not support an association between antibiotic-associated gut microbiome disruption and dementia risk.
引用
- Wang Y, Zhou Z, Broder JC, et al. Antibiotic Use and Subsequent Cognitive Decline and Dementia Risk in Healthy Older Adults. Neurology. 2024. PMID: 39693592. doi:10.1212/WNL.0000000000210129
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。